A novel nano-iron supplement versus standard treatment for iron deficiency anaemia in children 6-35 months (IHAT-GUT trial): a double-blind, randomised, placebo-controlled non-inferiority phase II trial in The Gambia.

Prevalence of moderate-severe diarrhoea The difference between the IHAT and FeSO 4 groups for prevalence of diarrhoea did not reach statistical significance, either in the CC-ITT population (OR FeSO4/IHAT 1.22, 80% CI 0.89–1.68) or the PP population (OR FeSO4/IHAT 1.18, 80% CI 0.86–1.62) ( Table 2 ).

also in 111,027 other papers